New training may ease lingering symptoms after mild brain injury
NCT ID NCT07356167
First seen Jan 23, 2026 · Last updated Jun 13, 2026 · Updated 17 times
Summary
This study aims to see if a new, low-risk therapy called passive neurosensory reintegration training (PNRT) can help reduce dizziness and other symptoms in people with mild traumatic brain injury (mTBI). Researchers will enroll 80 adults with mTBI to test the therapy's safety and effectiveness. The approach uses gentle sensory exercises to retrain the brain and improve recovery.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for MILD TRAUMATIC BRAIN INJURY are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
University of Miami Miller School of Medicine - Don Soffer Clinical Research Building
RECRUITINGMiami, Florida, 33136, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.